Surgery Partners (NASDAQ:SGRY – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Surgery Partners to post earnings of $0.07 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its quarterly earnings data on Monday, February 26th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $735.40 million for the quarter, compared to the consensus estimate of $741.93 million. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.22 EPS. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Surgery Partners Trading Up 0.9 %
Shares of SGRY opened at $24.76 on Tuesday. The company has a current ratio of 1.71, a quick ratio of 1.57 and a debt-to-equity ratio of 0.89. Surgery Partners has a 1-year low of $22.05 and a 1-year high of $45.79. The firm’s 50-day moving average price is $28.30 and its 200-day moving average price is $29.78. The firm has a market capitalization of $3.15 billion, a price-to-earnings ratio of -247.60, a PEG ratio of 2.24 and a beta of 2.71.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Surgery Partners
Insiders Place Their Bets
In other news, CEO Jason Eric Evans sold 4,840 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total value of $143,796.40. Following the completion of the sale, the chief executive officer now directly owns 459,670 shares in the company, valued at approximately $13,656,795.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Jason Eric Evans sold 4,840 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total transaction of $143,796.40. Following the completion of the transaction, the chief executive officer now directly owns 459,670 shares in the company, valued at approximately $13,656,795.70. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO David T. Doherty sold 2,306 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $31.89, for a total transaction of $73,538.34. Following the completion of the sale, the chief financial officer now directly owns 75,229 shares of the company’s stock, valued at $2,399,052.81. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 18,774 shares of company stock worth $608,352. Company insiders own 2.60% of the company’s stock.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More
- Five stocks we like better than Surgery Partners
- Short Selling: How to Short a Stock
- 3 Trend-Following Entries for Income Investors
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Stocks Mega Investors Are Buying
- Manufacturing Stocks Investing
- Can Disney Stock Triple Before 2030?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.